Africa: TB screening must match HIV:
This article was originally published in Clinica
Africa is succeeding in rapidly increasing testing for HIV among TB patients, but the same cannot be said of TB screening of HIV/AIDS patients. So says the World Health Organization (WHO) in its Global TB Control Report. Greater collaboration is needed, it says, in the management of the two conditions. Despite the recent "unprecedented collaboration" between the TB and HIV communities, "much more is needed if we are to achieve our goal of universal access to quality prevention and diagnostic and treatment services", said Dr Peter Piot, UNAIDS executive director.
You may also be interested in...
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.